Issue Title
Vol 22, No 1 (2020) ELEVATE-TN Study. New data of acalabrutinib in first-line treatment of chronic lymphocytic leukemia. Resolution
Abstract PDF
(Rus)
Poddubnaya I.V., Al-Radi L.S., Byalik T.E., Kaplanov K.D., Molostvova V.Z., Nikitin E.A., Pospelova T.I., Ptushkin V.V., Samoilova O.S., Stadnik E.A., Tumyan G.S.
Vol 21, No 4 (2019) The role of second generation Bruton tyrosine kinase inhibitors in the treatment of chronic lymphocytic leukemia. Resolution
Abstract PDF
(Rus)
Poddubnaya I.V., Bialik T.E., Glonina N.N., Kalashnikova O.B., Kaplanov K.D., Lapin V.A., Medvedeva N.V., Mikhailova N.B., Moiseeva T.N., Nikitin E.A., Pospelova T.I., Stadnik E.A.
Vol 15, No 3 (2013) Bevatsizumab v kombinatsii s khimioluchevoy terapiey u bol'nykh glioblastomoy
Abstract
Smolin A.V., Konev A.V., Kobyakov G.L., Nikolaeva S.N., Shamanskaya Y.E., Gorbunov A.V.
Vol 15, No 1 (2013) Current approach to adjuvant therapy for breast cancer (a review)
Abstract
Conte P., Guarneri V.
Vol 16, No 2 (2014) First results of the Russian multicenter epidemiology project on the malignant gliomas
Abstract
Smolin A.V., Bekyashev A.H., Kobyakov G.L., Sharabura T.M., Mufazalov F.F., Kanischeva N.V., Bumagina V.O.
Vol 17, No 4 (2015) Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas
Abstract
Borisov P.S., Orlova R.V., Shkolnik M.I., Karlov P.A.
Vol 16, No 1 (2014) New aspects of the first-line chemotherapy in colorectal cancer
Abstract
Artamonova E.V.
Vol 10, No 3 (2008) Tsetuksimab v lechenii ryada solidnykh opukholey: dostizheniya i perspektivy
Abstract
Besova N.S., Khokhlova S.V., Romanov I.S., Gorbunova V.A., Matyakin E.G.
Vol 16, No 3 (2014) Bevacizumab in advanced ovarian cancer: when, what for and why?
Abstract
Tjulandina A.S.
Vol 19, No 1 (2017) The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor
Abstract PDF
(Rus)
Ryazhenov V.V.
Vol 9, No 3 (2007) Perspektivy ispol'zovaniya Tsetuksimaba pri zlokachestvennykh opukholyakh tolstoy kishki i opukholyakh golovy i shei
Abstract
Khokhlova S.V., Romanov I.S., Gorbunova V.A., Matyakin E.G.
Vol 16, No 4 (2014) The effect of combinated treatment of a metastatic HER2-positive stomach cancer
Abstract
Khvastunov R.A., Nenarokomov A.Y., Tolstopiatov S.E., Babina K.G.
Vol 18, No 4 (2016) Molecular genetic features of the head and neck (upper aerodigestive tract) mucosal melanoma
Abstract
Ignatova A.V.
Vol 9, No 3 (2007) Targetnaya terapiya raka pochki
Abstract
Alekseev B.Y., Shegay P.V.
Vol 16, No 3 (2014) HER2-positive disseminated gastric and gastro-oesophageal junction adenocarcinoma: forecast, clinical course, treatment
Abstract
Besova N.S.
Vol 15, No 1 (2013) Preliminary results of an observational program for estimating the duration of bevacizumab therapy in patients with metastatic colorectal cancer in daily clinical practice
Abstract
Poddubnaya I.V., Bobrovskaya E.V., Vladimirova L.Y., Gordeev S.S., Davidenko I.S., Emelyanov S.A., Zharkova O.V., Koroleva I.A., Krasilnikova S.Y., Maikoparova S.C., Malysheva T.A., Modestov A.A., Morozov A.N., Stachenko G.B., Strygina E.A., Tlish E.K., Feoktistova P.S., Chichkanova A.S., Sherman N.Z.
Vol 18, No 2 (2016) Prognostic factors in patients with disseminated gastrointestinal stromal tumors
Abstract PDF
(Rus)
Arkhiri P.P., Stilidi I.S., Poddubnaya I.V., Nered S.N., Nikulin M.P., Abu-Khaydar O.B.
Vol 9, No 3 (2007) Ingibitory vnutrikletochnoy peredachi signala pri melanome: perspektivy i razocharovaniya targetnoy terapii
Abstract
Konstantinova M.M.
Vol 11, No 4 (2009) Tartseva (erlotinib) v terapii rasprostranennoy adenokartsinomy legkogo pri nalichii mutatsii retseptora epidermal'nogo faktora rosta
Abstract
Orlov S.V., Dvorakovskaya I.V., Mosin I.V., Stel'makh L.V., Gorokhov A.A., Martynenko O.N., Poltoratskiy A.N.
Vol 18, No 1 (2016) Klinicheskie sluchai lecheniya gepatotsellyulyarnogo raka v Rossii. Klinicheskiy sluchay 1 Bolee chem 3-letnyaya stabilizatsiya protsessa gepatotsellyulyarnogo raka na fone dlitel'nogo priema preparata sorafenib
Abstract PDF
(Rus)
Sheko S.S., Dem'yanova G.A.
Vol 9, No 3 (2007) Sutent® (Sutent, SU11248) – novyy mul'titargetnyy ingibitor angiogeneza opukholey
Abstract
Imyanitov E.N.
Vol 16, No 1 (2014) Clinical cases of treatment of hepatocellular carcinoma
Abstract
Lazarev S.A., Mamontov K.G., Manihas G.M., Antimonik N.Y.
Vol 11, No 4 (2009) Press-reliz Na XIII Rossiyskom kongresse onkologov obsudili sostoyanie epidemiologicheskoy programmy skrininga HER2-statusa u zhenshchin, bol'nykh rakom molochnoy zhelezy (RMZh), a takzhe preimushchestvai perspektivy targetnoy terapii preparatami Gertseptin i Avastin
Abstract
Vol 17, No 3 (2015) Current understanding of the role of insulin-like and vascular endothelial growth factors in development, prognosis and targeted therapy in patients with ovarian cancer
Abstract
Knyazev R.I., Poddubnaya I.V., Barinov V.V., Bokin I.I.
Vol 9, No 2 (2007) Sravnitel'noe issledovanie opredeleniya NER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii
Abstract
Zavalishina L.E., Andreeva Y.Y., Ryazantseva A.A., Bateva M.V., Frank G.A.
Vol 16, No 1 (2014) The Avastin application in clinical practice in patients with metastatic colorectal cancer: Second interim analysis of the observational AJAX program
Abstract
Poddubnaya I.V., Bichurina S.A., Bobrovskaya E.V., Vladimirova L.Y., Gordeev S.S., Davidenko I.S., Emelyanov S.A., Zharkova O.V., Koroleva I.A., Krasilnikova S.Y., Maikoparova S.C., Malysheva T.A., Modestov A.A., Morozov A.N., Petrukhnenko V.A., Sivunova I.D., Stachenko G.B., Strygina E.A., Tlish E.K., Feoktistova P.S., Chichkanova A.S., Sherman N.Z.
Vol 11, No 3 (2009) Rol' pemetrekseda (Alimta) v lechenii rasprostranennogo neploskokletochnogonemelkokletochnogo raka legkogo
Abstract
Poddubnaya I.V.
Vol 16, No 2 (2014) New horizons in skin malignancies treatment
Abstract
Gamaunov S.V.
Vol 11, No 3 (2009) Targetnaya terapiya rasprostranennogo raka pochki: problema vybora preparata na primere mul'tikinaznykh ingibitorov
Abstract
Matveev V.B.
Vol 17, No 4 (2015) Modern possibilities of targeted therapy in metastatic colorectal cancer
Abstract
Gorbunova V.A.
Vol 11, No 3 (2009) Gertseptin: mekhanizm deystviya
Abstract
Imyanitov E.N.
Vol 17, No 1 (2015) The role of targeted therapy in the treatment of advanced hepatocellular carcinoma
Abstract
Shakhnovich E.B., Kerbikov O.B., Kulaga E.A.
Vol 15, No 4 (2013) Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney
Abstract
Klimenko A.A., Ivanov S.A.
Vol 19, No 4 (2017) Clinical cases of the treatment of metastatic colorectal cancer in Russia
Abstract PDF
(Rus)
Goldberg V.E., Hasanova A.I., Shkuratova V.V., Belevich Y.V., Popova N.O., Simolina E.I., Vysockaya V.V., Dudnikova E.A., Kravchuk T.L., Minnabetdinova R.R., Nekrasova O.V.
Vol 11, No 2 (2009) Vozmozhnosti ispol'zovaniya tsetuksimaba dlya lecheniya bol'nykh kolorektal'nym rakom
Abstract
Orlova R.V., Tyukavina N.V.
Vol 16, No 3 (2014) Russian multicenter retrospective study: preliminary data concerning clinical and molecular genetic characteristics in long-term responders to erlotinib
Abstract
Smolin A.V., Gorbacheva A.V.
Vol 15, No 3 (2013) Retseptor faktora rosta fibroblastov 1-go tipa kak mishen' tselenapravlennoy terapii pochechno-kletochnogo raka
Abstract
Timofeev I.V.
Vol 19, No 2 (2017) Targeted therapy in pediatric malignancies treatment: Pediatric Oncology and Haematology Research Institute experience
Abstract PDF
(Rus)
Valiev T.T., Levashov A.S., Batmanova N.A., Senzhapova E.R., Turupaev K.A., Tomchik U.V., Aleskerova G.A.
Vol 16, No 3 (2014) Modern options in personalized therapy of metastatic cutaneous melanoma
Abstract
Protsenko S.A., Novik A.V., Akhaeva Z.Y., Zhabina A.S., Imyanitov E.N., Semenova A.I.
Vol 15, No 3 (2013) Targetnaya terapiya metastaticheskogo raka zheludka: klinicheskiy opyt uspeshnogo lecheniya patsienta s retsidivom raka zheludka
Abstract
Tlish E.K.
Vol 19, No 2 (2017) The treatment of patients with advanced lung cancer associated with EGFR mutation
Abstract PDF
(Rus)
Bolotina L.V.
Vol 9, No 4 (2007) Erbituks – ratsional'no sozdannyy preparat dlya lecheniya zlokachestvennykh opukholey
Abstract
Garin A.M., Bazin I.S., Nasyrova R.Y.
1 - 42 of 42 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies